Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Finding the right no fee cash back card can enhance your savings. Discover which card suits your financial habits best.
26,735 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Starlink’s rumored mobile service could shake up how Americans connect on the go. This guide breaks down what that me...
When a CEO discloses a sale of 41,600 shares, investors pay attention. This article unpacks the implications, the mec...
As markets wobble in early 2026, a handful of Dow Jones dividend stocks offer reliable income for retirees. This repo...
A seasoned investor reveals a stubborn bet on Microsoft, arguing that the company’s dual engine—legacy software profi...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
A circulating XRPL proposal aims to build a dedicated sidechain for exchange-grade options trading, linking it back t...
SpaceX’s IPO frenzy has cooled, dragging crypto-linked bets with it. A looming unlock window, plus a sharp pullback i...
Tokenized stocks are moving from concept to reality as major exchanges edge toward on-chain equity trading. This repo...
A Kentucky hospitalist spends half the year caring for patients in the U.S. and the other half in Venice, Italy, livi...
The VIX slid as optimism about geopolitical peace and cheaper oil spurred a broad market rally. Analysts caution the ...